Vimarsana
Biggest News Aggregation in the World

Page 29 - Ar T News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ar T. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ar T Today - Breaking & Trending Today

Leading medical device company to build Center for - Vimarsana News

Leading medical device company to build Center for

ThermoGenesis’ new facility anticipates quadrupling production efficiency and halving costs of life-saving therapies...

Yale scientists energize CAR-T cancer immunotherapy by hitting the gas on metabolism - Vimarsana News

Yale scientists energize CAR-T cancer immunotherapy by hitting the gas on metabolism

Scientists at Yale University have found a way to enhance the cancer-killing power of CAR-T cells by reprogramming an amino acid metabolism pathway.

'WWE 2K22': Logan Paul, Machine Gun Kelly, others announced as DLC characters - Vimarsana News

'WWE 2K22': Logan Paul, Machine Gun Kelly, others announced as DLC characters

'WWE 2K22': Logan Paul, Machine Gun Kelly, others announced as DLC characters. 2K Sports' WWE 2K22 on Thursday revealed its post-launch content updates through July, which includes new playable characters such as YouTube star Logan Paul, rapper Machine Gun Kelly and actor Mr. T, among others.

Fierce Pharma Asia—Legend CEO's cell therapy ambitions; Indian pharmas' awkward position; new Hutchmed CEO - Vimarsana News

Fierce Pharma Asia—Legend CEO's cell therapy ambitions; Indian pharmas' awkward position; new Hutchmed CEO

After its first commercial launch in Carvykti, Legend Biotech's CEO talked up the rising CAR-T star's cell therapy ambitions.

With J&J-partnered CAR-T nod in hand, Legend CEO eyes earlier myeloma use, cheaper cell therapy manufacturing - Vimarsana News

With J&J-partnered CAR-T nod in hand, Legend CEO eyes earlier myeloma use, cheaper cell therapy manufacturing

Nearly five years after unveiling the first clinical data for its BCMA-targeted CAR-T therapy, Legend Biotech has transitioned into a commercial company with an FDA approval for Carvykti and Johnso